SUNPHARMA.NS Balance Sheet
Sun Pharmaceutical Industries Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 01:42
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹10,390.38 Cr. | ₹10,192.32 Cr. | ₹10,035.94 Cr. | ₹11,114.11 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹963.35 Cr. | ₹1,107.73 Cr. | ₹1,234.34 Cr. | ₹1,380.65 Cr. | CapitalWorkInProgress |
| Goodwill | ₹8,712.71 Cr. | ₹8,598.95 Cr. | ₹8,939.42 Cr. | ₹9,833.08 Cr. | Goodwill |
| Other Intangible Assets | ₹5,317.03 Cr. | ₹4,420.11 Cr. | ₹3,610.92 Cr. | ₹11,875.08 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹5,068.09 Cr. | ₹5,998.62 Cr. | ₹4,248.97 Cr. | ₹3,789.07 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹2,679.35 Cr. | ₹2,758.96 Cr. | ₹960.79 Cr. | ₹1,116.13 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹40,860.25 Cr. | ₹41,987.90 Cr. | ₹39,476.11 Cr. | ₹44,894.03 Cr. | NoncurrentAssets |
| Inventories | ₹10,513.05 Cr. | ₹9,868.29 Cr. | ₹10,243.33 Cr. | ₹11,492.93 Cr. | Inventories |
| Trade Receivables | ₹11,438.51 Cr. | ₹11,249.37 Cr. | ₹13,046.11 Cr. | ₹15,509.67 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹4,623.73 Cr. | ₹9,285.65 Cr. | ₹10,268.77 Cr. | ₹9,770.51 Cr. | CashAndCashEquivalents |
| Current Investments | ₹9,372.61 Cr. | ₹8,584.54 Cr. | ₹13,656.10 Cr. | ₹20,933.45 Cr. | CurrentInvestments |
| Other Current Assets | ₹1,961.65 Cr. | ₹2,228.01 Cr. | ₹2,527.86 Cr. | ₹2,864.77 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹39,861.94 Cr. | ₹43,433.11 Cr. | ₹52,594.06 Cr. | ₹63,860.29 Cr. | CurrentAssets |
| Total Assets | ₹80,743.59 Cr. | ₹85,462.88 Cr. | ₹92,100.58 Cr. | ₹1,08,785.22 Cr. | Assets |
| Equity Share Capital | ₹239.93 Cr. | ₹239.93 Cr. | ₹239.93 Cr. | ₹239.93 Cr. | EquityShareCapital |
| Other Equity | ₹55,755.45 Cr. | ₹63,426.82 Cr. | ₹71,978.09 Cr. | ₹83,330.16 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹55,995.38 Cr. | ₹63,666.75 Cr. | ₹72,218.02 Cr. | ₹83,570.09 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹3,320.09 Cr. | ₹3,439.22 Cr. | ₹267.93 Cr. | ₹309.65 Cr. | NonControllingInterest |
| Total Equity | ₹59,315.47 Cr. | ₹67,105.97 Cr. | ₹72,485.95 Cr. | ₹83,879.74 Cr. | Equity |
| Long-term Borrowings | ₹0.00 Cr. | ₹1.33 Cr. | ₹2.52 Cr. | ₹31.26 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹1,521.12 Cr. | ₹1,372.51 Cr. | ₹1,420.42 Cr. | ₹2,283.44 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹6,197.88 Cr. | ₹2,844.36 Cr. | ₹1,867.11 Cr. | ₹4,050.35 Cr. | BorrowingsCurrent |
| Trade Payables | ₹5,681.52 Cr. | ₹5,653.30 Cr. | ₹6,184.34 Cr. | ₹7,333.80 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹642.72 Cr. | ₹1,084.46 Cr. | ₹1,169.79 Cr. | ₹1,187.53 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹19,906.38 Cr. | ₹16,983.77 Cr. | ₹18,194.21 Cr. | ₹22,622.04 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹80,743.59 Cr. | ₹85,462.88 Cr. | ₹92,100.58 Cr. | ₹1,08,785.22 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from SUNPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).